It has been a wild ride for Hims & Hers (NYSE: HIMS) shareholders over the last few years. The stock is currently in a 65% drawdown from its highs, but up 50% in March, due to the telehealth platform's latest deal with a weight-loss drugmaker that was formerly suing it. Now, Hims & Hers is teaming up with its former enemies. Here are two S&P 500 index stocks to watch after this latest Hims & Hers stock move, and what it means for the future of the weight-loss market. Will AI create the world's first trill ...